Psychosocial Impact of Dysarthria: The Patient-Reported Outcome as Part of the Clinical Management.


Journal

Neuro-degenerative diseases
ISSN: 1660-2862
Titre abrégé: Neurodegener Dis
Pays: Switzerland
ID NLM: 101189034

Informations de publication

Date de publication:
2019
Historique:
received: 14 12 2018
accepted: 14 03 2019
pubmed: 22 5 2019
medline: 25 8 2020
entrez: 22 5 2019
Statut: ppublish

Résumé

Dysarthria in neurological disorders can have psychosocial consequences. The dysarthric speaker's perspective towards the disorder's psychosocial impact is essential in its global assessment and management. For such purposes, assessment tools such as the Dysarthria Impact Profile (DIP) are indispensable. We aimed to confirm the relevance of using the DIP to quantify the psychosocial consequences of dysarthria in neurological diseases. We studied 120 participants, 15 healthy controls and 105 patients with different kinds of dysarthria induced by several neurological disorders (Parkinson's disease [PD], Huntington's disease, dystonia, cerebellar ataxia, progressive supranuclear palsy [PSP], multiple system atrophy, lateral amyotrophic sclerosis). All participants underwent a cognitive evaluation and a speech intelligibility assessment and completed three self-reported questionnaires: the 36-Item Short Form Health Survey, the Voice Handicap Index (VHI), and the DIP. The psychometric properties of the DIP were confirmed, including internal consistency (α = 0.93), concurrent validity (correlation with the VHI: r = -0.77), and discriminant validity (accuracy = 0.93). Psychosocial impact of dysarthria was revealed by the DIP for all patients. Intelligibility loss was found strongly correlated with the psychosocial impact of dysarthria: for a similar level of intelligibility impairment, the DIP total score was similar regardless of the pathological group. However, our findings suggest that the psychosocial impact measured by the DIP could be partially independent from the severity of dysarthria (indirectly addressed here via speech intelligibility): the DIP was able to detect patients without any intelligibility impairment, but with a psychosocial impact. All patients reported a communication complaint, attested by the DIP scores, despite the fact that not all patients, notably PD, ataxic, and PSP patients, had an intelligibility deficit. The DIP should be used in clinical practice to contribute to a holistic evaluation and management of functional communication in patients with dysarthria.

Sections du résumé

BACKGROUND
Dysarthria in neurological disorders can have psychosocial consequences. The dysarthric speaker's perspective towards the disorder's psychosocial impact is essential in its global assessment and management. For such purposes, assessment tools such as the Dysarthria Impact Profile (DIP) are indispensable.
OBJECTIVE
We aimed to confirm the relevance of using the DIP to quantify the psychosocial consequences of dysarthria in neurological diseases.
METHODS
We studied 120 participants, 15 healthy controls and 105 patients with different kinds of dysarthria induced by several neurological disorders (Parkinson's disease [PD], Huntington's disease, dystonia, cerebellar ataxia, progressive supranuclear palsy [PSP], multiple system atrophy, lateral amyotrophic sclerosis). All participants underwent a cognitive evaluation and a speech intelligibility assessment and completed three self-reported questionnaires: the 36-Item Short Form Health Survey, the Voice Handicap Index (VHI), and the DIP.
RESULTS
The psychometric properties of the DIP were confirmed, including internal consistency (α = 0.93), concurrent validity (correlation with the VHI: r = -0.77), and discriminant validity (accuracy = 0.93). Psychosocial impact of dysarthria was revealed by the DIP for all patients. Intelligibility loss was found strongly correlated with the psychosocial impact of dysarthria: for a similar level of intelligibility impairment, the DIP total score was similar regardless of the pathological group. However, our findings suggest that the psychosocial impact measured by the DIP could be partially independent from the severity of dysarthria (indirectly addressed here via speech intelligibility): the DIP was able to detect patients without any intelligibility impairment, but with a psychosocial impact.
CONCLUSIONS
All patients reported a communication complaint, attested by the DIP scores, despite the fact that not all patients, notably PD, ataxic, and PSP patients, had an intelligibility deficit. The DIP should be used in clinical practice to contribute to a holistic evaluation and management of functional communication in patients with dysarthria.

Identifiants

pubmed: 31112944
pii: 000499627
doi: 10.1159/000499627
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-21

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Cyril Atkinson-Clement (C)

Brain and Spine Institute (ICM), Team Movement Investigation and Therapeutics, Paris, France, cyril.atkinsonclement@gmail.com.

Alban Letanneux (A)

University of East-Paris-Est, Créteil, CHArt (EA 4004), UPEC-ESPE, Bonneuil-sur-Marne, France.

Guillaume Baille (G)

Department of Neurology and Movement Disorders, CHU, Lille, France, INSERM UMR_S 1171, Lille, France, University of Lille, Lille, France.

Marie-Charlotte Cuartero (MC)

Aix-Marseille Université, CNRS, LPL, Aix-en-Provence, France.

Lauriane Véron-Delor (L)

Aix-Marseille Université, CNRS, LPL, Aix-en-Provence, France.
Aix-Marseille Université, CNRS, LNC, Marseille, France.

Camille Robieux (C)

Aix-Marseille Université, CNRS, LPL, Aix-en-Provence, France.

Manon Berthelot (M)

Aix-Marseille Université, CNRS, LPL, Aix-en-Provence, France.

Danièle Robert (D)

Aix-Marseille Université, CNRS, LPL, Aix-en-Provence, France.
Aix-Marseille Université, Hôpital de la Conception, ENT Department, Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Jean-Philippe Azulay (JP)

Aix-Marseille Université, CNRS, INT, Inst Neurosci Timone, Marseille, France.
Aix-Marseille Université, APHM, CHU Timone, Department of Neurology and Movement Disorders, Marseille, France.

Luc Defebvre (L)

Department of Neurology and Movement Disorders, CHU, Lille, France, INSERM UMR_S 1171, Lille, France, University of Lille, Lille, France.

Joaquim Ferreira (J)

Campus Neurológico Sénior (CNS), Torres Vedras, Portugal.

Alexandre Eusebio (A)

Aix-Marseille Université, CNRS, INT, Inst Neurosci Timone, Marseille, France.
Aix-Marseille Université, APHM, CHU Timone, Department of Neurology and Movement Disorders, Marseille, France.

Caroline Moreau (C)

Department of Neurology and Movement Disorders, CHU, Lille, France, INSERM UMR_S 1171, Lille, France, University of Lille, Lille, France.

Serge Pinto (S)

Aix-Marseille Université, CNRS, LPL, Aix-en-Provence, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH